HBV launches proprietary multi-strategy fund

HBV Capital Management, a US-based hedge fund group, has launched a multi-strategy fund investing in its three existing hedge funds.

HBV, an SEC-registered investment adviser with more than $550m (€626m), will include its US risk arbitrage, European risk arbitrage and hedged distressed investments strategies via a single vehicle.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump